A detailed history of Vivo Capital, LLC transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Vivo Capital, LLC holds 4,034,522 shares of ALXO stock, worth $7.54 Million. This represents 1.07% of its overall portfolio holdings.

Number of Shares
4,034,522
Previous 4,220,048 4.4%
Holding current value
$7.54 Million
Previous $25.4 Million 71.15%
% of portfolio
1.07%
Previous 3.76%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$1.81 - $8.13 $335,802 - $1.51 Million
-185,526 Reduced 4.4%
4,034,522 $7.34 Million
Q3 2020

Nov 13, 2020

BUY
$29.36 - $47.1 $124 Million - $199 Million
4,220,048 New
4,220,048 $159 Million

Others Institutions Holding ALXO

About ALX ONCOLOGY HOLDINGS INC


  • Ticker ALXO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,747,100
  • Market Cap $76.2M
  • Description
  • ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...
More about ALXO
Track This Portfolio

Track Vivo Capital, LLC Portfolio

Follow Vivo Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vivo Capital, LLC with notifications on news.